Kisqali

Indicated For

HR+, HER2- early breast cancer (eBC), HR+, HER2- metastatic breast cancer (mBC)

About This Medication

# How to Get Kisqali (Ribociclib) Through the Novartis Patient Assistance Foundation (NPAF) ## Who Qualifies for the Novartis Patient Assistance Foundation (NPAF)? If you cannot afford Kisqali (ribociclib), you may qualify to receive it at no cost through the **Novartis Patient Assistance Foundation (NPAF)**. This program is designed specifically for patients who are uninsured, underinsured, or enrolled in Medicare Part D with a coverage gap. To be eligible, a single-person household must have an annual income at or below **$75,300**. Larger households may qualify at higher income limits. You must also be a U.S. resident and have a valid prescription from a licensed healthcare provider. Patients with active commercial insurance that covers Kisqali are typically directed to a separate copay savings program rather than this foundation. If you meet the income and insurance criteria, NPAF may provide your Kisqali at no charge, shipped directly to your home. --- ## About Kisqali (Ribociclib) Kisqali (ribociclib) is a prescription medication made by Novartis. It belongs to a class of drugs called CDK4/6 inhibitors. It is used to treat hormone receptor-positive, HER2-negative (HR+, HER2-) breast cancer in both early-stage (eBC) and metastatic (mBC) forms. Kisqali is taken in combination with other therapies as directed by your oncologist. Without insurance or financial assistance, Kisqali can cost several thousand dollars per month, placing it out of reach for many patients. The NPAF program exists to help close that gap for patients who meet the eligibility requirements. No FDA-approved biosimilar versions of Kisqali are currently available, which means there is no lower-cost substitute on the market at this time. --- ## Income Eligibility: Full Breakdown NPAF uses income thresholds set at **500% of the Federal Poverty Level (FPL)**, which is standard for Novartis Oncology patient assistance programs. Your eligibility is based on your total household income, not just your personal earnings. The current income limits are: | Household Size | Maximum Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | Income is typically verified using your most recent federal tax return (Form 1040), a W-2, or a Social Security Award Letter. If your income has changed significantly from last year, ask your prescriber's office whether recent pay stubs or other documentation may be accepted. If your income is above the limit for your household size, you may not qualify for NPAF at this time. However, you should still explore the manufacturer savings card program if you have private insurance, or look into state pharmaceutical assistance programs (SPAPs), which sometimes have different income thresholds. Even if you are over the limit today, your circumstances may change — the program can be checked again at any time. --- ## Insurance Requirements Explained Your insurance status plays a major role in which Novartis program you are directed to. Here is how different situations are handled: - **If you are uninsured:** You may be eligible for NPAF and could receive Kisqali at no cost, provided you meet the income requirements. - **If you have Medicare Part D:** You may qualify for NPAF, particularly if you have a coverage gap (sometimes called the "donut hole") or your out-of-pocket costs are unaffordable. Medicare patients are generally not eligible for manufacturer copay cards, making NPAF one of the few options available to you. - **If you have private insurance that covers less than 50% of the cost (underinsured):** You may qualify for NPAF. Patients whose insurance leaves them with a significant financial burden are considered on a case-by-case basis. - **If you have Medicaid:** Federal rules generally prohibit pharmaceutical manufacturers from providing free drugs to Medicaid beneficiaries. If you are enrolled in Medicaid, you likely will not qualify for NPAF. Contact your Medicaid plan or a patient advocate to explore other options. --- ## Step-by-Step: How to Apply Follow these steps to apply for Kisqali through the NPAF program: 1. **Gather your documents before you start.** You will need: a completed NPAF application form (with both your signature and your prescriber's signature), proof of income (your most recent federal tax return/Form 1040, W-2, or Social Security Award Letter), and a valid prescription for Kisqali. 2. **Choose how to apply.** You have multiple options: - **Online:** Visit [https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-assistance-foundation-inc](https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-assistance-foundation-inc) to access the application portal. - **By phone:** Call **(800) 282-7630** to speak with a program representative who can guide you through the process. - **By fax:** Send your completed application and supporting documents to **(855) 817-2711**. 3. **Have your prescriber complete their section.** The application requires a licensed prescriber's signature. Many oncology offices are familiar with this process and can assist you. 4. **Submit all documents together.** Incomplete applications can delay processing. Double-check that every required document is included before submitting. 5. **Wait for a determination.** NPAF typically reviews applications within **2 business days**. You or your prescriber's office will be notified of the decision. 6. **If approved, confirm your shipping address.** Medication is shipped directly to your home, so make sure your address on the application is current and correct. --- ## What to Expect: Timeline and Delivery After you submit a complete application, NPAF typically completes its review within **2 business days**. You or your prescriber will receive confirmation of the approval decision. If approved, Kisqali will be **shipped directly to your home address** — you do not need to pick it up at a pharmacy or your doctor's office. There is nothing additional required at the time of delivery. Keep in mind that NPAF approval is not permanent. You will need to **reauthorize your enrollment once per year** to continue receiving the medication. Watch for renewal notices and make sure your income documentation stays up to date so there is no gap in your supply. --- ## Alternatives If You Don't Qualify If you do not meet the NPAF eligibility requirements, there are still options worth exploring: 1. **Biosimilars:** There are currently no FDA-approved biosimilar versions of Kisqali available. This option is not available at this time. 2. **Manufacturer savings card (insured patients):** If you have commercial (private) insurance, you may qualify for the Kisqali savings card program, which can reduce your out-of-pocket costs significantly. You can learn more at [https://www.kisqali.com/early-breast-cancer/cost-and-support/novartis-patient-support](https://www.kisqali.com/early-breast-cancer/cost-and-support/novartis-patient-support). 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states offer their own drug assistance programs with different income limits and eligibility rules. Your state health department or a social worker at your oncology center can help you find what is available in your state. 4. **NeedyMeds.org:** This free, nonprofit database lists hundreds of patient assistance programs, disease-based assistance funds, and other drug cost resources. Visit [www.needymeds.org](https://www.needymeds.org) to search by medication name or diagnosis. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novartis. Program terms may change — verify current requirements at [https://www.kisqali.com/financial-support](https://www.kisqali.com/financial-support) before applying.* ---

Program information last verified: February 27, 2026